Comparing lung surgery with and without enhanced recovery methods
Official title: The Short Term and Long Term Comparison of Lung Surgery With or Without Enhanced Recovery
Run by The Second Hospital of Shandong University · NCT04451473 · Data updated 2026-11-12
This study is testing if using special recovery methods after lung surgery helps people with lung cancer recover better than traditional care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | The Second Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | October 8, 2019 |
| Main results expected | June 30, 2023 |
| Study ends | June 30, 2027 |
| Registry record updated | November 16, 2022 |
| Trial ID | NCT04451473 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with stage I-IIIa non-small-cell lung cancer who require radical resection or VATS surgery.
✕Probably not a fit
Patients with cardio-pulmonary conditions that prevent them from tolerating surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effects of Enhanced Recovery After Surgery (ERAS) protocols on patients undergoing lung resection for primary lung cancer. Patients will be randomly assigned to either an ERAS group, which follows enhanced recovery practices, or a control group that receives traditional perioperative management. The study will collect and compare short-term and long-term outcomes between these two groups to assess the benefits of the ERAS approach. The goal is to provide data that could improve recovery and outcomes for lung cancer surgery patients.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery times and better long-term outcomes for patients undergoing lung surgery.
How similar studies have gone: Other studies have shown promising results with ERAS protocols in various surgical fields, suggesting potential benefits in lung surgery as well.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical resection or other benign lung lesions need VATS surgery. \- Exclusion Criteria: cardio-pulmonary function couldn't tolerate surgery \-
Where it's running
-
Yunpeng Zhao
Jinan, Shandong, China Recruiting
Study contacts
- Study coordinator: Yunpeng Zhao, Doctor
- Email: zhaoyunpengsddx@sdu.edu.cn
- Phone: 17660081916
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.